Searched for
MALARIA VACCINE DEVELOPMENT
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Ebola virus in India? Here's the latest update on the Bengaluru scare, symptoms and precautions explainedEbola virus in Bangalore: A woman returning from Uganda was quarantined in Bengaluru with Ebola-like symptoms. Her tests have come back neg...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Chhattisgarh proposes to use security camps as 'Seva Kendras'Chhattisgarh's Chief Minister, Vishnu Deo Sai, has launched an innovative program aimed at revitalizing inactive police and paramilitary ca...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- Expert panel has recommended that India doesn't fall within criteria for adopting malaria vaccines: GovtAn expert panel suggests India need not adopt malaria vaccines. These vaccines are for areas with moderate to high transmission. They are a...
- Development of indigenous multi-stage Malaria vaccine 'AdFalciVax' is underwayIndia is developing a new malaria vaccine. The Indian Council of Medical Research is leading the effort. The vaccine is called AdFalciVax. ...
- Bharat Biotech, GSK to halve price of malaria vaccine by 2028Drugmakers Bharat Biotech and GSK will reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028, more than halving the ...
- SII commences shipments of malaria vaccine 'R21/Matrix-M' to AfricaSerum Institute of India (SII) commenced exporting the 'R21/Matrix-M' malaria vaccine to Africa in collaboration with the University of Oxf...
- WHO expert panel recommends Oxford University-Serum Institute's anti-malaria vaccineThe R21/Matrix-M™ malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many ...
- Oxford-Serum malaria vaccine wins WHO's recommendationThe R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale at a modest cost, enabling as many ...
- UN authorises 2nd malaria vaccine, developed by Oxford University with help from Serum Institute of IndiaResearch suggests it is more than 75% effective and that protection is maintained for at least another year with a booster. Tedros said the...
- Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccineThe R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months - the age gro...
- Oxford, Serum Institute of India: New Anti-Malaria vaccine trial over, authorization next yearThe phase 3 trial of the R21 malaria vaccine, also known as Matrix-M and developed by the Jenner Institute at the University of Oxford, has...
- DCGI allows Serum Institute to export malaria vaccine to UKIndia's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the Univer...
- WHO approved a malaria vaccine for children – a global health expert explains why that is a big dealApproval of the RTS,S/AS01 vaccine, which goes by the name Mosquirix, provides a "glimmer of hope" for Africa, according to Dr. Matshidiso ...
- WHO recommends world's first malaria vaccine for children at riskThe decision followed a review of a pilot programme deployed since 2019 in Ghana, Kenya and Malawi in which more than two million doses wer...
- New malaria vaccine generates robust immune responseA new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...
- 'Self-sabotage' prevents immune protection against malariaMalaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the deadly disease, scientists...
- Cadila Pharmaceuticals and Novavax to develop malaria vaccine using virus like particle technologyCadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.
Load More
